BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Personalized medicine
,
Doxorubicin
,
rs2300478
,
FABP1
,
calcium channel activity
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
ki- antigen
Summary
General Info
Curated Studies
Most Correlated Studies
Thymic stromal cell subsets; age and biomarker comparisons
Explore Curated Studies Results
Literature
Most Relevant Literature
The 20S proteasome activator PA28γ controls the compaction of chromatin.
Comprehensive analysis of PSME3: from pan-cancer analysis to experimental validation.
circFANCA accelerates the malignant process of OSCC by modulating miR-34a/PA28γ signaling.
Cold temperature extends longevity and prevents disease-related protein aggregation through PA28γ-in…
PQBP3 prevents senescence by suppressing PSME3-mediated proteasomal Lamin B1 degradation.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen Vaccine and Nivolumab in Treating Patien…
Study to Compare the Efficacy of GSK Biologicals' Adjuvants in Combination With the Antigen of the H…
Soy Protein Supplement in Preventing Prostate Cancer in Patients With Elevated Prostate-Specific Ant…
Evaluation of Prostate-specific Membrane Antigen (PSMA)-Based PET Imaging of Primary Prostate Cancer
Abbreviated 3 Cycles of Rituximab Plus CHOP(Cyclophosphamide, Adriamycin, Vincristine, and Prednisol…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ